Home › Research › Down syndrome and Alzheimer's
Automated Plasma Phospho-tau217 Assays for the diagnosis of Down Syndrome-Related Alzheimer's Disease
Rafii M, Langford O, Schlachetzki Z, Zammit M, Donohue M, Zhou X, Sukreet S, Abdel-Latif S et al.. Research Square, 2025-09-01
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
Individuals with Down syndrome (DS) develop a genetic form of Alzheimer’s disease (AD) due to an extra copy of chromosome 21, which contains the APP gene. The widespread implementation of blood-based biomarkers for AD is imminent. These tests hold promise for diagnosing AD in DS once validated. In this study, we assessed plasma phospho-tau217 (p-tau217) in participants from the NIH Trial Ready Cohort – Down syndrome (TRC-DS), using predefined amyloid PET cutoffs. Plasma p-tau217 was measured via two fully automated assays: C2N Diagnostics’ PrecivityAD2 mass spectrometry and Fujirebio’s Lumipulse immunoassay. The primary outcome was AD pathology, defined by amyloid PET >18 centiloids. Both assays showed high accuracy: AUCs of 0.92 and 0.90, with sensitivities of 0.88 and specificities of 0.94 and 0.90, respectively. These results are comparable to composite plasma measures. In conclusion, automated p-tau217 tests offer strong potential for routine AD screening in individuals with DS.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Rafii, M., Langford, O., Schlachetzki, Z., Zammit, M., Donohue, M., Zhou, X., et al. (2025). Automated Plasma Phospho-tau217 Assays for the diagnosis of Down Syndrome-Related Alzheimer's Disease. Research Square. https://doi.org/10.21203/rs.3.rs-7359108/v1
Vancouver
Rafii M, Langford O, Schlachetzki Z, Zammit M, Donohue M, Zhou X, et al. Automated Plasma Phospho-tau217 Assays for the diagnosis of Down Syndrome-Related Alzheimer's Disease. Research Square. 2025. doi:10.21203/rs.3.rs-7359108/v1.
BibTeX
@article{rafii2025-763c19f0,
author = {Rafii, M. and Langford, O. and Schlachetzki, Z. and Zammit, M. and Donohue, M. and Zhou, X. and Sukreet, S. and Abdel-Latif, S. and others},
title = {{Automated Plasma Phospho-tau217 Assays for the diagnosis of Down Syndrome-Related Alzheimer's Disease}},
journal = {Research Square},
year = {2025},
doi = {10.21203/rs.3.rs-7359108/v1},
url = {https://doi.org/10.21203/rs.3.rs-7359108/v1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- These results are comparable to composite plasma measures.
- In conclusion, automated p-tau217 tests offer strong potential for routine AD screening in individuals with DS.
Study details
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 23 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 14 of the 62 points we could judge it on, which is 23 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (Research Square) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 14 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 14 of the 62 points we could judge it on is 23 out of 100. |
| Total | 23 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.